We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

24 hedge funds and large institutions have $15.7M invested in La Jolla Pharmaceutical Company in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+24
Holders Change %
–
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$2.94M
2
BBA
Baker Bros. Advisors
New York
+$2.17M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.1M
4
BGA
Belmont Global Advisors
Texas
+$1.82M
5
EI
EAM Investors
California
+$1.46M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$3.24M +$2.94M +300,000 New
BBA
2
Baker Bros. Advisors
New York
$2.39M +$2.17M +221,631 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.31M +$2.1M +213,573 New
BGA
4
Belmont Global Advisors
Texas
$2M +$1.82M +185,000 New
EI
5
EAM Investors
California
$1.61M +$1.46M +149,143 New
IHM
6
Iguana Healthcare Management
New York
$1.22M +$1.1M +112,500 New
TMC
7
Trellus Management Company
Florida
$500K +$454K +46,300 New
RFC
8
Russell Frank Company
Washington
$416K +$378K +38,497 New
SIM
9
Spark Investment Management
New York
$300K +$273K +27,800 New
Renaissance Technologies
10
Renaissance Technologies
New York
$296K +$269K +27,400 New
TAM
11
Tocqueville Asset Management
New York
$289K +$262K +26,725 New
Jane Street
12
Jane Street
New York
$220K +$200K +20,381 New
CS
13
Credit Suisse
Switzerland
$199K +$181K +18,437 New
TCM
14
Tang Capital Management
California
$121K +$110K +11,219 New
Citigroup
15
Citigroup
New York
$121K +$110K +11,225 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$121K +$111K +11,264 New
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
$108K +$98.1K +10,000 New
Morgan Stanley
18
Morgan Stanley
New York
$98K +$88.8K +9,050 New
PAM
19
Panagora Asset Management
Massachusetts
$67K +$60.9K +6,208 New
Wells Fargo
20
Wells Fargo
California
$46K +$41.7K +4,250 New
WA
21
WFG Advisors
Texas
$14K +$13.1K +1,339 New
TRCT
22
Tower Research Capital (TRC)
New York
$6K +$5.32K +542 New
Deutsche Bank
23
Deutsche Bank
Germany
$6K +$5.89K +600 New
U
24
UBS
Switzerland
$1K +$863 +88 New

LJPC Hedge Fund Activity: Q1 2014 in Review

24 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q1 2014, worth a combined $15.7M.

Buyers outnumbered sellers: 24 funds opened new LJPC positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Broadfin Capital, opening a new position worth an estimated $2.94M.

  • 24 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $15.7M of La Jolla Pharmaceutical Company stock for Q1 2014.
  • 24 funds opened new La Jolla Pharmaceutical Company positions in Q1 2014 and 0 closed out, a net change of +24 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q1 2014 was Broadfin Capital, an estimated $2.94M added.

Based on aggregated 13F filings for Q1 2014.